What does Herseltpharma do?

Herseltpharma is a pharmacy in Herselt. Private Limited, started on 4 October 2007, 1 establishment.

What is the address of Herseltpharma?

The registered office of Herseltpharma is located at Dorp 50, 2230 Herselt.

Is Herseltpharma still active?

Yes. According to the CBE (30 September 2026) Herseltpharma is active, legal situation “Normale toestand”, started on 4 October 2007.

Is Herseltpharma registered on Peppol?

Yes, Herseltpharma is registered on the Peppol network with ID 0208:0892542332.

What is the enterprise number of Herseltpharma?

The enterprise number of Herseltpharma is BE0892542332.

When was Herseltpharma founded?

Herseltpharma was founded on 4 October 2007.

Who are the directors of Herseltpharma?

According to the 2025 annual accounts, the directors of Herseltpharma are: Kathleen Gielis.

Is Herseltpharma a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 October 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Herseltpharma make in 2025?

Herseltpharma posted a profit after taxes of € 268,806 in financial year 2025.

What is the revenue of Herseltpharma?

As a small company, Herseltpharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 821,455.

How much does an employee at Herseltpharma earn?

The average wage cost per full-time employee at Herseltpharma was € 65,800 in 2025: staff costs of € 243,487 for 3.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Herseltpharma have?

According to the 2025 annual accounts, Herseltpharma has 3.7 full-time equivalents (FTE).

Herseltpharma (Private Limited) - Herselt - BE0892542332

Dossier Herseltpharma, printed on 30 September 2026 from databakkes.be/en/0892542332/herseltpharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Herseltpharma from Herselt, company number BE0892542332, closed financial year 2025 with a result of € 268,806 after tax. For that financial year Herseltpharma recorded a gross margin of € 821,455 and equity of € 920,049. Compared with financial year 2024, the result moved from € 95,906 to € 268,806. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.

What it is worth Growing

€ 920,049

▲ 17% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 268,806

▲ 180% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 110,889

▲ 3% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 136,717 paid out

51 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

3.7

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 243,487

▲ 18% vs 2024

€ 65,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 11,207

▼ 42% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 193,340

▼ 33% vs 2024

€ 94,784 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 119,534

▼ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 63,151

▲ 21% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 449,096 Gross margin 2022: € 449,096 First fiscal year in the series	€ 506,814 Gross margin 2023: € 506,814 ▲ 13% vs 2022 (€ 449,096) Favourable step	€ 563,105 Gross margin 2024: € 563,105 ▲ 11% vs 2023 (€ 506,814) Favourable step	€ 821,455 Gross margin 2025: € 821,455 ▲ 46% vs 2024 (€ 563,105) Favourable step	▲ 46%
Profit after taxes	€ 84,957 Profit after taxes 2022: € 84,957 First fiscal year in the series	€ 130,178 Profit after taxes 2023: € 130,178 ▲ 53% vs 2022 (€ 84,957) Favourable step	€ 95,906 Profit after taxes 2024: € 95,906 ▼ 26% vs 2023 (€ 130,178) Unfavourable step	€ 268,806 Profit after taxes 2025: € 268,806 ▲ 180% vs 2024 (€ 95,906) Favourable step	▲ 180%
Equity	€ 617,554 Equity 2022: € 617,554 First fiscal year in the series	€ 692,055 Equity 2023: € 692,055 ▲ 12% vs 2022 (€ 617,554) Favourable step	€ 787,961 Equity 2024: € 787,961 ▲ 14% vs 2023 (€ 692,055) Favourable step	€ 920,049 Equity 2025: € 920,049 ▲ 17% vs 2024 (€ 787,961) Favourable step	▲ 17%
Total debts	€ 888,260 Total debts 2022: € 888,260 First fiscal year in the series	€ 879,979 Total debts 2023: € 879,979 ▼ 1% vs 2022 (€ 888,260) Favourable step	€ 739,669 Total debts 2024: € 739,669 ▼ 16% vs 2023 (€ 879,979) Favourable step	€ 391,907 Total debts 2025: € 391,907 ▼ 47% vs 2024 (€ 739,669) Favourable step	▼ 47%
Cash	€ 93,041 Cash 2022: € 93,041 First fiscal year in the series	€ 205,491 Cash 2023: € 205,491 ▲ 121% vs 2022 (€ 93,041) Favourable step	€ 107,792 Cash 2024: € 107,792 ▼ 48% vs 2023 (€ 205,491) Unfavourable step	€ 110,889 Cash 2025: € 110,889 ▲ 3% vs 2024 (€ 107,792) Favourable step	▲ 3%
Land & buildings	€ 70,470 Land & buildings 2022: € 70,470 First fiscal year in the series	€ 63,417 Land & buildings 2023: € 63,417 ▼ 10% vs 2022 (€ 70,470) Unchanged	€ 56,363 Land & buildings 2024: € 56,363 ▼ 11% vs 2023 (€ 63,417) Unchanged	-
Retained profit	€ 553,954 Retained profit 2022: € 553,954 First fiscal year in the series	€ 628,455 Retained profit 2023: € 628,455 ▲ 13% vs 2022 (€ 553,954) Favourable step	€ 724,361 Retained profit 2024: € 724,361 ▲ 15% vs 2023 (€ 628,455) Favourable step	€ 856,449 Retained profit 2025: € 856,449 ▲ 18% vs 2024 (€ 724,361) Favourable step	▲ 18%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 55,677 Dividend 2023: € 55,677 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 55,677) Unchanged	€ 136,717 Dividend 2025: € 136,717 Unchanged (€ 0) Unchanged
Bank debt	€ 481,203 Bank debt 2022: € 481,203 First fiscal year in the series	€ 386,867 Bank debt 2023: € 386,867 ▼ 20% vs 2022 (€ 481,203) Favourable step	€ 290,444 Bank debt 2024: € 290,444 ▼ 25% vs 2023 (€ 386,867) Favourable step	€ 193,340 Bank debt 2025: € 193,340 ▼ 33% vs 2024 (€ 290,444) Favourable step	▼ 33%
Balance sheet total	€ 1,505,813 Balance sheet total 2022: € 1,505,813 First fiscal year in the series	€ 1,572,034 Balance sheet total 2023: € 1,572,034 ▲ 4% vs 2022 (€ 1,505,813) Unchanged	€ 1,527,630 Balance sheet total 2024: € 1,527,630 ▼ 3% vs 2023 (€ 1,572,034) Unchanged	€ 1,311,956 Balance sheet total 2025: € 1,311,956 ▼ 14% vs 2024 (€ 1,527,630) Unchanged	▼ 14%
Employees (FTE)	3.6 Employees (FTE) 2022: 3.6 First fiscal year in the series	3.5 Employees (FTE) 2023: 3.5 ▼ 0.1 vs 2022 (3.6) Unchanged	3.7 Employees (FTE) 2024: 3.7 ▲ 0.2 vs 2023 (3.5) Unchanged	3.7 Employees (FTE) 2025: 3.7 Unchanged (3.7) Unchanged

Key figures of Herseltpharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Herseltpharma?

What happened at Herseltpharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 16, 2026 New annual accounts for financial year 2025: profit of € 268,806 (▲ 180% vs 2024). Source: NBB ↗
Oct 4, 2007 New establishment in Herselt. KBO
Oct 4, 2007 Start of the company according to the CBE. KBO

In short

From € 84,957 profit in 2022 to € 268,806 profit in 2025.

Paid € 291,907 in corporate taxes since 2022.

Best year ever: 2025, with € 268,806 profit.

On average € 222,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at Herseltpharma? We notify you, reason included.

Follow Herseltpharma

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Kathleen Gielis

Herseltpharma

MIJN APOTHEEK

Behind Herseltpharma is Kathleen Gielis. Kathleen Gielis is also behind MIJN APOTHEEK.

See the full network in the app

Directors

According to the 2025 annual accounts

Kathleen Gielis

Director

Also active at: MIJN APOTHEEK

Establishments

Establishment units

Physical locations of this company

Registered office

Dorp 50

2230 Herselt

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0892.542.332

VAT number

BE 0892.542.332

Registered office

Dorp 50, 2230 Herselt

Names & denominations

Herseltpharma

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

4 October 2007

Peppol

Active · Active since 27 Jun 2025

Activities · NACE

Detailhandel in farmaceutische producten

Activiteiten van holdings

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

Herseltpharma

Financials

What happened to Herseltpharma?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions